The Research Triangle Park company expects a federal decision in October. It's also advancing gene therapy programs for ...

The global eyeglasses market is projected to grow at a rate of 7% over the next five years, driven by several key factors. These include the rising prevalence of refractive errors and vision disorders ...

EyePoint Pharmaceuticals (EYPT) remains a 'Sell' as current valuation prices in significant success for Duravyu despite ...

"Your eyes are truly the windows to the soul and adds to one being unapologetically present and purpose-filled.” ...

Enrollment completion in the OCU400 Phase 3 clinical trial combined with positive 3-year data from the Phase 1/2 study are important accomplishments in the Company’s plan to begin bringing this ...

Robot Phones, Ultrathin Foldables, Cutting-Edge Cameras: CNET's Favorite Tech from MWC 2026 ...

Duker indicated that EyePoint expects to report top line data for the Phase III LUGANO trial in mid-2026 with LUCIA data to follow closely, complete enrollment in the pivotal Phase III DME program in ...

RBL LLC biotechnology startup SteerBio to drive clinical development and commercializationHOUSTON, /PRNewswire/ --A team of researchers led ...

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.It seems too simple to be true that we could ...

Alhaji Oladotun Odunaye retired at the directorate level from the Independent National Electoral Commission (INEC) in 2016, after decades of service in Ogun and Edo states and electoral assignments in ...

Model Kai Schreiber, 17, joins her mum Naomi Watts in this cover story for THE FACE, for a candid, healing conversation from ...